Effect of pharmacist intervention on herpes zoster vaccination in community pharmacies

Journal of the American Pharmacists Association

Volumn 53, Issue 1, 2013, Pages 46-53

  Wang, Junling ^a   Ford, Lindsay J ^b   Wingate, La'Marcus ^a   Uroza, Sarah Frank ^c   Jaber, Nina ^d   Smith, Cindy T ^e,f   Randolph, Richard ^g   Lane, Steve ^h   Foster, Stephan L ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c LIPSCOMB UNIVERSITY   (United States)

^d Capital Regional Medical Center   (United States)

^e Reeves Sain Drug Store   (United States)

^f University of Tennessee ^*  (United States)

^g Marcrom's Pharmacy   (United States)

^h Wilson Pharmacy   (United States)

Author keywords

Community pharmacy; Interventions; Vaccinations; Zoster vaccine

Indexed keywords

VARICELLA ZOSTER VACCINE;

ARTICLE; DEMOGRAPHY; HEALTH SERVICE; HERPES ZOSTER; HUMAN; INTERVENTION STUDY; PATIENT SATISFACTION; PHARMACIST; PRESCRIPTION; RURAL AREA; UNITED STATES; VACCINATION; AGED; CLINICAL TRIAL; FEMALE; FINANCIAL MANAGEMENT; HEALTH PROMOTION; MALE; MEDICAL RECORD; MIDDLE AGED; MULTICENTER STUDY; ORGANIZATION AND MANAGEMENT; PATIENT ATTITUDE; PATIENT EDUCATION; PHARMACY; PROCEDURES; PROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COMMUNITY PHARMACY SERVICES; FEMALE; HEALTH PROMOTION; HERPES ZOSTER VACCINE; HUMANS; MALE; MARKETING OF HEALTH SERVICES; MEDICAL RECORDS; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT EDUCATION AS TOPIC; PHARMACISTS; PROSPECTIVE STUDIES; TENNESSEE;

EID: 84890091439     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2013.12019     Document Type: Article

References (25)

1. Gershon AA, Gershon MD, Breuer J, et al. Advances in the understanding of the pathogenesis and epidemiology of herpes zoster. J Clin Virol. 2010;48(suppl 1):S2-7.
2. Ragozzino MW, Melton LJ 3rd, Kurland LT, et al. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore). 1982;61(5):310-6.
3. Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med. 1965;58:9-20.
4. Merck. Zostavax: highlights of prescribing information. www.merck. com/product/usa/pi-circulars/z/zostavax/zostavax-pi2.pdf. Accessed December 23, 2011.
5. Harpaz R, Ortega-Sanchez IR, Seward JF. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008;57(RR-5):1-30.
6. Lu PJ, Euler GL, Harpaz R. Herpes zoster vaccination among adults aged 60 years and older, in the U.S., 2008. Am J Prev Med. 2011;40(2):e1-6.
7. Hogue MD, Grabenstein JD, Foster SL, Rothholz MC. Pharmacist involvement with immunizations: a decade of professional advancement. J Am Pharm Assoc. 2006;46(2):168-79.
8. American Pharmacists Association, Academy of Managed Care Pharmacy. Pharmacist-provided immunization compensation and recognition: white paper summarizing APhA/AMCP stakeholder meeting. J Am Pharm Assoc. 2011;51(6):704-12.
9. Neuhauser MM, Wiley D, Simpson L, Garey KW. Involvement of immu-nization- certified pharmacist with immunization activities. Ann Pharmacother. 2004;38(2):226-31.
10. Grabenstein JD, Guess HA, Hartzema AG, et al. Effect of vaccination by community pharmacists among adult prescription recipients. Med Care. 2001;39(4):340-8.
11. Weitzel KW, Goode JV. Implementation of a pharmacy-based immunization program in a supermarket chain. J Am Pharm Assoc. 2000;40(2):252-6.
12. Bearden DT, Holt T. Statewide impact of pharmacist-delivered adult influenza vaccinations. Am J Prev Med. 2005;29(5):450-2.
13. Ernst ME, Bergus GR, Sorofman BA. Patients' acceptance of traditional and nontraditional immunization providers. J Am Pharm Assoc. 2001;40(1):53-9.
14. Grabenstein JD, Guess HA, Hartzema AG. People vaccinated by pharmacists: descriptive epidemiology. J Am Pharm Assoc. 2001;41(1):46-52.
15. Grabenstein JD. Pharmacists as vaccine advocates: roles in community pharmacies, nursing homes, and hospitals. Vaccine. 1998;16(18):1705-10.
16. Loughlin SM, Mortazavi A, Garey KW, et al. Pharmacist-managed vaccination program increased influenza vaccination rates in cardiovascular patients enrolled in a secondary prevention lipid clinic. Pharmacotherapy. 2007;27(5):729-33.
17. Van Amburgh JA, Waite NM, Hobson EH, Migden H. Improved influenza vaccination rates in a rural population as a result of a pharmacist-managed immunization campaign. Pharmacotherapy. 2001;21(9):1115-22.
18. Bounthavong M, Christopher ML, Mendes MA, et al. Measuring patient satisfaction in the pharmacy specialty immunization clinic: a pharma-cist- run Immunization Clinic at the Veterans Affairs San Diego Healthcare System. Int J Pharm Pract. 2010;18(2):100-7.
19. Taitel M, Cohen E, Terranova B, et al. Pharmacists as immunization providers: patient attitudes and perceptions. www.pharmacytimes.com/ publications/issue/2011/September2011/Pharmacists-as-Immunization-Providers- Patient-Attitudes-and-Perceptions. Accessed December 24, 2011.
20. Westrick SC. Pharmacy characteristics, vaccination service characteristics, and service expansion: an analysis of sustainers and new adopters. J Am Pharm Assoc. 2010;50(1):52-61.
21. Wood HM, McDonough RP, Doucette WR. Retrospective financial analysis of a herpes zoster vaccination program from an independent community pharmacy perspective. J Am Pharm Assoc. 2009;49(1):12-7.
22. U.S. Census Bureau. State and county quick facts. http://quickfacts. census.gov/qfd/states/47000.html. Accessed December 23, 2011.
23. Centers for Disease Control and Prevention. Vaccines and preventable diseases: herpes zoster vaccination for health care professionals. www.cdc.gov/vaccines/vpd-vac/shingles/hcp-vaccination.htm. Accessed March 31, 2012.
24. Hulley SB, Cummings SR. Designing clinical research. Baltimore, MD: Lippincott Williams & Wilkins; 1988:216-7.
25. Wind Y. Market segmentation. In: Baker MJ. Marketing theory: a student text. London: Thomson Learning; 2000:181.